Vyne Therapeutics Stock Story
| VYNE Stock | USD 2.57 0.20 7.22% |
About 53% of Vyne Therapeutics' investor base is interested to short. The analysis of the overall investor sentiment regarding Vyne Therapeutics suggests that many traders are impartial. Vyne Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Vyne Therapeutics. The current market sentiment, together with Vyne Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Vyne Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Vyne Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Vyne daily returns and investor perception about the current price of Vyne Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Vyne |
Requested story not found. it has been either deleted or moved. View all stories for Vyne Therapeutics.
Vyne Therapeutics Latest Timeline
Vyne Therapeutics is listed for 2.57. The company reported the previous year's revenue of 424 K. Net Loss for the year was (27.87 M) with profit before overhead, payroll, taxes, and interest of 477 K.Check out Vyne Therapeutics Hype Analysis, Vyne Therapeutics Correlation and Vyne Therapeutics Performance. For information on how to trade Vyne Stock refer to our How to Trade Vyne Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Vyne Stock analysis
When running Vyne Therapeutics' price analysis, check to measure Vyne Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vyne Therapeutics is operating at the current time. Most of Vyne Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vyne Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vyne Therapeutics' price. Additionally, you may evaluate how the addition of Vyne Therapeutics to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Vyne Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vyne Therapeutics. If investors know Vyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.72) | Revenue Per Share 0.041 | Quarterly Revenue Growth 11.667 | Return On Assets (0.26) | Return On Equity (0.46) |
The market value of Vyne Therapeutics is measured differently than its book value, which is the value of Vyne that is recorded on the company's balance sheet. Investors also form their own opinion of Vyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vyne Therapeutics' market value can be influenced by many factors that don't directly affect Vyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.